Page 3 - Gsk

Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs

More price increases are expected to be announced later this week, which could affect the median and range.

Pharma firms plan awareness drive to battle cancer scare in antacid

Indian companies have also been hit in their global business.

GSK seeks licence to market baby-friendly HIV drug dolutegravir

If approved by regulators, the medicine will be the first new generation HIV medicine available in baby-friendly form

Drug major GSK sold off up to 10 tail-end brands in FY19 including Celin

According to the firm's FY19 annual report, it fetched Rs 5 crore during the year from the sale of brands

GSK to invest Rs 1,000 cr in Karnataka for new plant

Factory to commence production from 2018

GSK files potential $1 billion shingles vaccine for US approval

Shingrix is viewed by analysts as among the British drugmaker most promising experimental products

GSK puts Mumbai land on the block again

The land parcel is valued between Rs 1,400 crore and Rs 1,800 crore

GSK Consumer valuation unsustainable

Revenues declined; competition led to higher ad spends and impacted profits